| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Take Your Curtain Calls Later! |
|
Useful Advices - Take Your Curtain Calls Later!
When I was a kid, we used to play a game of stealth around the schoolyard. We called it, “Ditch.” Sometime According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product s, we played in teams, and sometimes, as individual players. It was really hide-and-seek, but a “special fo ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rces” version. We tried to find the most obscure holes in which to hide, or the highest perches in trees, a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. d on occasion, we even scaled Spanish tile rooftops, and hid behind chimneys. Anyway, we’d sneak up on eac here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe h other, and say, gotcha, or you’re dead, or some other delightful thing. There was always a temptation to d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hout it out, because victory is exhilarating, but if we did, we’d give away our own locations. So, we muff ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc led our giggles, and stifled our shouts. And this is exactly what we should do when we’re achieving a brea easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi kthrough in business. I’ve had my share, and I’ve found it really pays to fly under the radar as long as y nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically u can, undetected, instead of dropping publicity posters proclaiming how smart you are. Why give a heads-u and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ p to potential competitors about where the gold is buried? Yet, this is an all too real temptation. Today ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi for instance, I received an invitation from my MBA Alma Mater about a program that is being put on by a co ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a mpany whose product is featured at Starbuck’s. Good for them, I say; they got distribution. But if you bal dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ance what they can get from speaking, with the dangers of what they’ll disclose, by crowing about their suc cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ess to lean and mean MBA candidates, and to their always malnourished professors, I don’t think the ledger tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen balances. The publicity isn’t worth the risk; even if they think they’ll recruit indentured servants, also t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel know as interns. I conducted nationwide seminars in my field, and looking back on them, I know now that th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ey contained far too much information. I launched the careers of at least two competitors I know of, and th y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ere’s no question they siphoned off a significant amount of business that would have flowed my way. So, by . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de all means, go out there and succeed. But keep your voice down, and don’t take any premature curtain calls. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip There will be ample time for those in retirement. Otherwise, someone may sneak up on you and say, “Gotcha! tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Choose a Merchant Processor Tax Advantages of a Home Business
|